Michele Wible, MS

Pfizer WW Research & Development

Disclosure(s): Pfizer: Employee and shareholder, Stocks/Bonds (Public Company)

Poster(s):

• (P-105) Aztreonam-Avibactam Compared with Adjunctive Colistin Combined with Meropenem for the Treatment of Serious Gram-Negative Bacterial Infections: Subgroup Analysis of the Phase 3 REVISIT Study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT